Systolic blood pressure and risk of valvular heart disease: a mendelian randomization study

Systolic blood pressure and risk of valvular heart disease: a mendelian randomization study

Weitere Versionen anzeigen (1)

<p><strong>Importance</strong> Modifiable risk factors for valvular heart disease remain largely unknown, which limits prevention and treatment.</p> <p><strong>Objective</strong> To assess the association between systolic blood pressure (BP) and major valv...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Nazarzadeh, M, Pinho-Gomes, A, Smith Byrne, K, Canoy, D, Raimondi, F, Ayala Solares, J, Otto, C, Rahimi, K
Format:	Journal article
Veröffentlicht:	American Medical Association 2019

Ähnliche Einträge

Systolic blood pressure and risk of valvular heart disease: A mendelian randomization study
von: Nazarzadeh, M, et al.
Veröffentlicht: (2019)

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation: a Mendelian randomization study
von: Nazarzadeh Larzjan, M, et al.
Veröffentlicht: (2021)

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
von: Rao, S, et al.
Veröffentlicht: (2023)

Long‐Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large‐Scale Routine Electronic Health Records
von: Jose Roberto Ayala Solares, et al.
Veröffentlicht: (2019-06-01)

Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: a Mendelian randomization study
von: Milad Nazarzadeh, et al.
Veröffentlicht: (2021-03-01)

Long-term exposure to elevated systolic blood pressure in predicting incident cardiovascular disease: evidence from large-scale routine electronic health records
von: Solares, JR, et al.
Veröffentlicht: (2019)

Systolic blood pressure and cardiovascular risk in patients with diabetes: a prospective cohort study
von: Rao, S, et al.
Veröffentlicht: (2022)

Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies
von: Nazarzadeh, M, et al.
Veröffentlicht: (2022)

Plasma lipids and risk of aortic valve stenosis: A Mendelian randomization study
von: Nazarzadeh, M, et al.
Veröffentlicht: (2020)

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation
von: Nazarzadeh, M, et al.
Veröffentlicht: (2020)

Multi-morbidity and blood pressure trajectories in hypertensive patients: a multiple landmark cohort study
von: Tran, J, et al.
Veröffentlicht: (2021)

Blood pressure-lowering treatment lowers mortality and cardiovascular disease risk, but whether effects differ at an arbitrary threshold of 140 mm Hg systolic blood pressure requires further research
von: Canoy, D, et al.
Veröffentlicht: (2018)

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation
von: Nazarzadeh, M, et al.
Veröffentlicht: (2021)

Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study.
von: Jenny Tran, et al.
Veröffentlicht: (2021-06-01)

Management of blood pressure in heart failure
von: Pinho-Gomes, A, et al.
Veröffentlicht: (2019)

Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials
von: Pinho-Gomes, A, et al.
Veröffentlicht: (2019)

Blood pressure treatment: how low should you go? – Authors' reply
von: Rahimi, K, et al.
Veröffentlicht: (2021)

Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)
von: Rahimi, K, et al.
Veröffentlicht: (2019)

Diastolic and systolic blood pressure and gout: a Mendelian randomization study
von: Yanfang Li, et al.
Veröffentlicht: (2024-05-01)

How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease?
von: Canoy, D, et al.
Veröffentlicht: (2022)

Intensive blood pressure lowering and risk of diabetes: Friend or foe?
von: Nazarzadeh, M, et al.
Veröffentlicht: (2019)

Heart Rate and Systolic Blood Pressure Variability on Recently Diagnosed Diabetics
von: Anaclara Michel-Chávez, et al.
Veröffentlicht: (2015-01-01)

Uterine leiomyoma causes an increase in systolic blood pressure: a two-sample Mendelian randomization study
von: Hui Xu, et al.
Veröffentlicht: (2024-05-01)

Predicting the risk of emergency admission with machine learning: Development and validation using linked electronic health records
von: Rahimian, F, et al.
Veröffentlicht: (2018)

Systolic blood pressure, heart rate, and outcomes in patients with coronary disease and heart failure
von: Islam Y. Elgendy, et al.
Veröffentlicht: (2020-02-01)

Heterogeneity between genetic variants as a proxy for pleiotropy in mendelian randomization - reply
von: Nazarzadeh, M, et al.
Veröffentlicht: (2019)

Predicting the risk of emergency admission with machine learning: Development and validation using linked electronic health records.
von: Fatemeh Rahimian, et al.
Veröffentlicht: (2018-11-01)

Heart rate based on electrocardiography (ECG) and its relationship with systolic blood pressure /
von: Siti Nurasma Jalaludin, 1987-, et al.
Veröffentlicht: (2010)

8.3 QUANTIFYING HEART AND ARTERIAL CONTRIBUTIONS TO CENTRAL BLOOD PRESSURE IN SYSTOLE
von: Samuel Vennin, et al.
Veröffentlicht: (2016-11-01)

The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports
von: Nazarzadeh, M, et al.
Veröffentlicht: (2022)

Mendelian randomization of plasma lipids and aortic valve stenosis: the importance of outlier variants and population stratification
von: Nazarzadeh, M, et al.
Veröffentlicht: (2020)

Genetically predicted differences in systolic blood pressure and risk of cardiovascular and noncardiovascular diseases: a Mendelian randomization study in Chinese adults
von: Clarke, R, et al.
Veröffentlicht: (2023)

Heart rate modulates the relationship of augmented systolic blood pressure with the blood natriuretic peptide levels
von: Hirofumi Tomiyama, et al.
Veröffentlicht: (2021-10-01)

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial
von: Michael Böhm, et al.
Veröffentlicht: (2016-02-01)

Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality
von: Rao, S, et al.
Veröffentlicht: (2023)

Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
von: Canoy, D, et al.
Veröffentlicht: (2022)

Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study
von: Hsien-Yu Fan, et al.
Veröffentlicht: (2023-01-01)

Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions
von: Canoy, D, et al.
Veröffentlicht: (2021)

“Path of the Heart” (The BPROAD Study) Addresses Optimal Systolic Blood Pressure for Patients With Diabetes
von: Ning Guang
Veröffentlicht: (2025-01-01)

Estimation of systolic blood pressure by Random Forest using heart sounds and a ballistocardiogram
von: Rafael Gonzalez-Landaeta, et al.
Veröffentlicht: (2022-10-01)